Brookstone Capital Management Eli Lilly & CO Transaction History

Brookstone Capital Management

$6.01 Billion
Q3 2024

A detailed history of Brookstone Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Brookstone Capital Management holds 33,029 shares of LLY stock, worth $26.3 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

33,029

Previous 30,940 6.75%

Holding current value

$26.3 Million

Previous $28 Million 4.46%

% of portfolio

0.49%

Previous 0.53%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$772.14 - $960.02 $1.61 Million - $2.01 Million	2,089 Added 6.75%	33,029 $29.3 Million
Q2 2024 Jul 18, 2024	BUY	$724.87 - $909.04 $1.85 Million - $2.33 Million	2,558 Added 9.01%	30,940 $28 Million
Q1 2024 Apr 15, 2024	BUY	$592.2 - $792.28 $2.64 Million - $3.54 Million	4,464 Added 18.66%	28,382 $22.1 Million
Q4 2023 Jan 11, 2024	BUY	$525.19 - $619.13 $614,472 - $724,382	1,170 Added 5.14%	23,918 $13.9 Million
Q3 2023 Oct 20, 2023	BUY	$434.7 - $599.3 $33,037 - $45,546	76 Added 0.34%	22,748 $12.2 Million
Q2 2023 Jul 11, 2023	SELL	$350.74 - $468.98 $139,945 - $187,123	-399 Reduced 1.73%	22,672 $10.6 Million
Q1 2023 Apr 18, 2023	SELL	$310.63 - $364.82 $854,543 - $1 Million	-2,751 Reduced 10.65%	23,071 $7.92 Million
Q4 2022 Jan 09, 2023	SELL	$321.55 - $374.67 $888,764 - $1.04 Million	-2,764 Reduced 9.67%	25,822 $0
Q3 2022 Oct 13, 2022	SELL	$296.48 - $337.87 $2.06 Million - $2.35 Million	-6,948 Reduced 19.55%	28,586 $9.28 Million
Q2 2022 Jul 11, 2022	BUY	$278.73 - $327.27 $1.82 Million - $2.14 Million	6,541 Added 22.56%	35,534 $11.7 Million
Q1 2022 Apr 12, 2022	BUY	$234.69 - $291.66 $400,146 - $497,280	1,705 Added 6.25%	28,993 $8.96 Million
Q4 2021 Jan 11, 2022	SELL	$224.85 - $279.04 $194,270 - $241,090	-864 Reduced 3.07%	27,288 $7.08 Million
Q3 2021 Nov 03, 2021	BUY	$221.6 - $272.71 $846,068 - $1.04 Million	3,818 Added 15.69%	28,152 $6.66 Million
Q2 2021 Jul 14, 2021	BUY	$180.55 - $233.54 $1.47 Million - $1.9 Million	8,140 Added 50.27%	24,334 $5.73 Million
Q1 2021 Apr 16, 2021	BUY	$164.32 - $212.72 $289,038 - $374,174	1,759 Added 12.19%	16,194 $3.03 Million
Q4 2020 Jan 13, 2021	BUY	$130.46 - $172.63 $154,464 - $204,393	1,184 Added 8.94%	14,435 $2.44 Million
Q3 2020 Oct 13, 2020	BUY	$146.22 - $169.13 $247,550 - $286,337	1,693 Added 14.65%	13,251 $1.96 Million
Q2 2020 Jul 21, 2020	SELL	$136.42 - $164.18 $25,510 - $30,701	-187 Reduced 1.59%	11,558 $1.9 Million
Q1 2020 Apr 14, 2020	BUY	$119.05 - $147.35 $15,714 - $19,450	132 Added 1.14%	11,745 $1.63 Million
Q4 2019 Jan 29, 2020	BUY	$106.92 - $132.43 $42,340 - $52,442	396 Added 3.53%	11,613 $1.53 Million
Q3 2019 Oct 18, 2019	BUY	$106.79 - $116.16 $30,007 - $32,640	281 Added 2.57%	11,217 $1.25 Million
Q2 2019 Jul 25, 2019	BUY	$110.79 - $129.32 $72,899 - $85,092	658 Added 6.4%	10,936 $1.21 Million
Q1 2019 Apr 18, 2019	SELL	$111.31 - $131.02 $28,717 - $33,803	-258 Reduced 2.45%	10,278 $1.33 Million
Q4 2018 Feb 06, 2019	SELL	$105.9 - $118.64 $4.7 Million - $5.27 Million	-44,403 Reduced 80.82%	10,536 $1.22 Million
Q3 2018 Nov 05, 2018	SELL	$85.86 - $107.31 $1.1 Million - $1.38 Million	-12,836 Reduced 18.94%	54,939 $5.9 Million
Q2 2018 Aug 06, 2018	SELL	$75.7 - $86.88 $670,626 - $769,669	-8,859 Reduced 11.56%	67,775 $5.78 Million
Q1 2018 Apr 23, 2018	BUY	$74.21 - $87.6 $4.91 Million - $5.8 Million	66,194 Added 634.04%	76,634 $5.93 Million
Q4 2017 Feb 07, 2018	SELL	$81.94 - $87.89 $5.43 Million - $5.82 Million	-66,244 Reduced 86.39%	10,440 $882,000
Q3 2017 Oct 31, 2017	SELL	$77.07 - $85.54 $343,346 - $381,080	-4,455 Reduced 5.49%	76,684 $6.56 Million
Q2 2017 Aug 08, 2017	BUY	N/A	81,139	81,139 $6.68 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.

Account

Brookstone Capital Management Eli Lilly & CO Transaction History